Articles from BIOTECH Patent News (March 1, 2002)

1-38 out of 38 article(s)

Title	Type	Words
Advanced Stent establishes research center for interventional cardiology.	Brief Article	796
Alexion and CuraGen establish drug target discovery alliance.	Brief Article	573
Alliance and Inhale expand particle processing technology agreement.	Brief Article	621
Altair Nanotechnologies and NTera file joint patent.	Brief Article	615
Ambion licenses RNA interference technology from MIT.	Brief Article	226
Anadys obtains United States patent.	Brief Article	30
Antares Pharma and MacroMed collaborate to develop gel systems.	Brief Article	530
Apolife obtains United States patent.	Brief Article	141
Atrix licenses Eligard prostate cancer products in Israel.	Brief Article	378
Bayer obtains United States patent.	Brief Article	54
Boston Biomedica launches pressure cycling technology.	Brief Article	803
Boston Heart Foundation obtains United States patent.	Brief Article	102
Boston University obtains United States patent.	Brief Article	173
Cell Therapeutics TRISENOX granted European authorization.	Brief Article	399
Collateral Therapeutics acquires rights to the EPAS1 gene.	Brief Article	212
Federal Court rules in AUGMENTIN patent challenge.	Brief Article	176
Fred Hutchinson Cancer Research Center obtains United States patent.	Brief Article	89
Genentech obtains United States patent.	Brief Article	74
GPC Biotech announces issuance of United States patent for detecting diseased cells.	Brief Article	289
House Ear Institute obtains United States patent.	Brief Article	65
ISIS obtains United States patent.	Brief Article	103
Isis obtains United States patent.	Brief Article	39
Merck Frosst obtains United States patent.	Brief Article	53
Merck obtains United States patent.	Brief Article	51
Millennium and PAION to collaborate on stroke program.		1151
MorphoSys wins final ruling in patent dispute with CAT.	Brief Article	540
Novo Nordisk obtains United States patent.	Brief Article	38
Pivotal patent issued to Bioscrypt for portable biometric devices.	Brief Article	388
Reliv receives United States patent for ReversAge.	Brief Article	196
The University of Mississippi Medical Center obtains United States patent.	Brief Article	66
Thomas Jefferson University obtains United States patent.	Brief Article	170
Transkaryotic reaches settlement in gene therapy patent interferences.	Brief Article	415
U.S. Genomics awarded pioneering patent.	Brief Article	578
University of California obtains United States patent.	Brief Article	214
Viragen granted interferon patent.	Brief Article	527
Xcyte Therapies announces issuance of patent.	Brief Article	551
Yale obtains United States patent.	Brief Article	161
ZymoGenetics files patent infringement suit against.	Brief Article	301